Exposing the Causal Effect of C-Reactive Protein on the Risk of Type 2 Diabetes Mellitus: A Mendelian Randomization Study
暂无分享,去创建一个
Liang Cheng | He Zhuang | Shuo Yang | Jun Zhang | Huijie Jiang | Liang Cheng | Huijie Jiang | Jun Zhang | He Zhuang | Shuo Yang | Song Wang | Song Wang | Zhuang He
[1] Qinghua Guo,et al. LncRNA2Target v2.0: a comprehensive database for target genes of lncRNAs in human and mouse , 2018, Nucleic Acids Res..
[2] An Pan,et al. Walnut Consumption Is Associated with Lower Risk of Type 2 Diabetes in Women12 , 2013, The Journal of nutrition.
[3] A. Olokoba,et al. Type 2 diabetes mellitus: a review of current trends. , 2012, Oman medical journal.
[4] S. Haffner,et al. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. , 2002, Diabetes.
[5] B. Aissani. Confounding by linkage disequilibrium , 2013, Journal of Human Genetics.
[6] Shahrul Mt-Isa,et al. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. , 2009, JAMA.
[7] Jonathan C. Cohen,et al. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). , 2005, The American journal of cardiology.
[8] Chong Shen,et al. Elevation of serum uric acid and incidence of type 2 diabetes: A systematic review and meta-analysis , 2016, Chronic diseases and translational medicine.
[9] Helen Schuilenburg,et al. Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes , 2009, Nature Genetics.
[10] Andrew D. Johnson,et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..
[11] Jiajie Peng,et al. InfAcrOnt: calculating cross-ontology term similarities using information flow by a random walk , 2018, BMC Genomics.
[12] Shuhui Liu,et al. Improving the measurement of semantic similarity by combining gene ontology and co-functional network: a random walk based approach , 2018, BMC Systems Biology.
[13] Jiajie Peng,et al. Measuring phenotype-phenotype similarity through the interactome , 2017, 2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
[14] A. Pradeep,et al. Crevicular Fluid and Serum Concentrations of Progranulin and High Sensitivity CRP in Chronic Periodontitis and Type 2 Diabetes , 2013, Disease markers.
[15] M. Asghari-Jafarabadi,et al. Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[16] Ying Ju,et al. Predicting Diabetes Mellitus With Machine Learning Techniques , 2018, Front. Genet..
[17] Alfonso Rodríguez-Patón,et al. Meta-Path Methods for Prioritizing Candidate Disease miRNAs , 2019, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[18] Ross M. Fraser,et al. Genetic studies of body mass index yield new insights for obesity biology , 2015, Nature.
[19] Xiangxiang Zeng,et al. Prediction of potential disease-associated microRNAs using structural perturbation method , 2017, bioRxiv.
[20] N. Sattar,et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. , 2002, Diabetes.
[21] Tanya M. Teslovich,et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.
[22] Libin Zhou,et al. C-reactive protein inhibits adipone ctin gene expression and secretion in 3 T 3L 1 adipocytes , 2007 .
[23] M. McCarthy,et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes , 2008, Nature Genetics.
[24] Jiajie Peng,et al. A novel method to measure the semantic similarity of HPO terms , 2017 .
[25] M. Nalls,et al. Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study , 2017, PLoS medicine.
[26] Jean Tichet,et al. A Polymorphism Within the G6PC2 Gene Is Associated with Fasting Plasma Glucose Levels , 2008, Science.
[27] Olena O Yavorska,et al. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data , 2017, International journal of epidemiology.
[28] Luigi Ferrucci,et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. , 2008, American journal of human genetics.
[29] Robert R. Henry,et al. Type 2 diabetes mellitus , 2015, Nature Reviews Disease Primers.
[30] S. Gudbjörnsdottir,et al. Decreased systolic blood pressure is associated with increased risk of all-cause mortality in patients with type 2 diabetes and renal impairment: A nationwide longitudinal observational study of 27,732 patients based on the Swedish National Diabetes Register , 2017, Diabetes & vascular disease research.
[31] George Davey Smith,et al. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.
[32] L. Chambless,et al. Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers , 2007, Diabetes Care.
[33] Jackie A Cooper,et al. Inflammation, Insulin Resistance, and Diabetes—Mendelian Randomization Using CRP Haplotypes Points Upstream , 2008, PLoS medicine.
[34] A. Gaw,et al. The Anatomy of a Clinical Trial , 2002, Medical Principles and Practice.
[35] T. Funahashi,et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. , 2003, Diabetes care.
[36] A. Gautier,et al. C-reactive protein , 2005 .
[37] M. Kubo,et al. Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study. , 2005, Diabetes care.
[38] Philippe Froguel,et al. Common genetic variation near MC4R is associated with waist circumference and insulin resistance , 2008, Nature Genetics.
[39] Liang Cheng,et al. BLAT2DOLite: An Online System for Identifying Significant Relationships between Genetic Sequences and Diseases , 2016, PloS one.
[40] G. Rutten,et al. Effect of six years intensified multifactorial treatment on levels of hs‐CRP and adiponectin in patients with screen detected type 2 diabetes: The ADDITION‐Netherlands randomized trial , 2015, Diabetes/metabolism research and reviews.
[41] Masamichi Okubo,et al. Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. , 2003, Diabetes care.
[42] N. Timpson,et al. BMI as a Modifiable Risk Factor for Type 2 Diabetes: Refining and Understanding Causal Estimates Using Mendelian Randomization , 2016, Diabetes.
[43] G. Russo,et al. Antihyperglycemic treatment in patients with type 2 diabetes in Italy: the impact of age and kidney function. , 2017, Oncotarget.
[44] M. Sandhu,et al. Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis , 2009, Diabetologia.
[45] F. Dudbridge,et al. Robust instrumental variable methods using multiple candidate instruments with application to Mendelian randomization , 2016, 1606.03729.
[46] F. Schwartz,et al. Is type 2 diabetes an autoimmune-inflammatory disorder of the innate immune system? , 2005, Endocrinology.
[47] K. Kim. Effect of different training mode on Interleukin-6 (IL-6) and C-reactive protein (CRP) in type 2 diabetes mellitus (T2DM) patients , 2014, Journal of exercise nutrition & biochemistry.
[48] Jun Zhang,et al. Identifying diseases-related metabolites using random walk , 2018, BMC Bioinformatics.
[49] F. Hartwig,et al. Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique , 2016, International journal of epidemiology.
[50] Libin Zhou,et al. C-reactive protein inhibits adiponectin gene expression and secretion in 3T3-L1 adipocytes. , 2007, The Journal of endocrinology.
[51] G. Tan,et al. Relationship of the Serum CRP Level With the Efficacy of Metformin in the Treatment of Type 2 Diabetes Mellitus: A Meta‐Analysis , 2016, Journal of clinical laboratory analysis.
[52] Ayellet V. Segrè,et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height , 2010, Nature.
[53] Jie Sun,et al. DincRNA: a comprehensive web-based bioinformatics toolkit for exploring disease associations and ncRNA function , 2018, Bioinform..
[54] Montgomery Slatkin,et al. Linkage disequilibrium — understanding the evolutionary past and mapping the medical future , 2008, Nature Reviews Genetics.
[55] F. Hu,et al. The global implications of diabetes and cancer , 2014, The Lancet.
[56] D. Atar,et al. Type 2 Diabetes and Heart Failure - More Scrutiny Wanted! , 2017, Cardiology.
[57] G. Davey Smith,et al. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.
[58] C. Hoggart,et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population , 2008, Nature Genetics.
[59] Zhaohui S. Qin,et al. A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.
[60] Meng Zhou,et al. MetSigDis: a manually curated resource for the metabolic signatures of diseases , 2019, Briefings Bioinform..